Urinary microRNAs and Their Significance in Prostate Cancer
Diagnosis: A 5-Year Update

J 2022

Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update

JURÁČEK, Jaroslav, Marie MĄDRZYK, Michal STANÍK and Ondřej SLABÝ

Basic information

Original name

Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update

Authors

JURÁČEK, Jaroslav (203 Czech Republic), Marie MĄDRZYK (203 Czech Republic, belonging to the institution), Michal STANÍK (703 Slovakia) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution)

Edition

CANCERS, MDPI, 2022, 2072-6694

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 5.200

RIV identification code

RIV/00216224:14740/22:00128636

Organization unit

Central European Institute of Technology

DOI

http://dx.doi.org/10.3390/cancers14133157

UT WoS

000825500800001

Keywords in English

prostate cancer; microRNA; urine; extracellular vesicles; diagnosis

Abstract

V originále

Simple Summary Current diagnostics of prostate cancer often show unsatisfactory results, leading to delayed detection or overtreatment. Urinary microRNAs are a class of promising non-invasive biomarkers. Although many studies have been conducted on this topic in the last five years, there is little agreement on the data obtained. This review aims to discuss new knowledge but also focuses on technical aspects affecting urinary miRNA analysis. Current routine screening methods for the diagnosis of prostate cancer (PCa) have significantly increased early detection of the disease but often show unsatisfactory analytical parameters. A class of promising markers represents urinary microRNAs (miRNAs). In the last five years, there has been an extensive increase in the number of studies on this topic. Thus, this review aims to update knowledge and point out technical aspects affecting urinary miRNA analysis. The review of relevant literature was carried out by searching the PubMed database for the keywords: microRNA, miRNA, urine, urinary, prostate cancer, and diagnosis. Papers discussed in this review were retrieved using PubMed, and the search strategy was as follows: (urine OR urinary) WITH (microRNA OR miRNA) AND prostate cancer. The search was limited to the last 5 years, January 2017 to December 2021. Based on the defined search strategy, 31 original publications corresponding to the research topic were identified, read and reviewed to present the latest findings and to assess possible translation of urinary miRNAs into clinical practice. Reviews or older publications were read and cited if they valuably extended the context and contributed to a better understanding. Urinary miRNAs are potentially valuable markers for the diagnosis of prostate cancer. Despite promising results, there is still a need for independent validation of exploratory data, which follows a strict widely accepted methodology taking into account the shortcomings and factors influencing the analysis.

Links

NV18-03-00360, research and development project

Name: Využití močových/tkáňových mikroRNA k navýšení specificity PSA a odlišení indolentní a agresivní formy karcinomu prostaty

Investor: Ministry of Health of the CR, Usage of urinary/tissue microRNAs to increase PSA specificity and distinguish between indolent and aggressive forms of prostate cancer

Citovat

JURÁČEK, Jaroslav, Marie MĄDRZYK, Michal STANÍK and Ondřej SLABÝ. Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update. CANCERS. MDPI, 2022, vol. 14, No 13, p. 3157-3173. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers14133157.

@article{2255498,
   author = {Juráček, Jaroslav and Mądrzyk, Marie and Staník, Michal and Slabý, Ondřej},
   article_number = {13},
   doi = {http://dx.doi.org/10.3390/cancers14133157},
   keywords = {prostate cancer; microRNA; urine; extracellular vesicles; diagnosis},
   language = {eng},
   issn = {2072-6694},
   journal = {CANCERS},
   title = {Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update},
   url = {https://www.mdpi.com/2072-6694/14/13/3157},
   volume = {14},
   year = {2022}
}

TY  - JOUR
ID  - 2255498
AU  - Juráček, Jaroslav - Mądrzyk, Marie - Staník, Michal - Slabý, Ondřej
PY  - 2022
TI  - Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update
JF  - CANCERS
VL  - 14
IS  - 13
SP  - 3157
EP  - 3157
PB  - MDPI
SN  - 20726694
KW  - prostate cancer
KW  - microRNA
KW  - urine
KW  - extracellular vesicles
KW  - diagnosis
UR  - https://www.mdpi.com/2072-6694/14/13/3157
N2  - Simple Summary Current diagnostics of prostate cancer often show unsatisfactory results, leading to delayed detection or overtreatment. Urinary microRNAs are a class of promising non-invasive biomarkers. Although many studies have been conducted on this topic in the last five years, there is little agreement on the data obtained. This review aims to discuss new knowledge but also focuses on technical aspects affecting urinary miRNA analysis. Current routine screening methods for the diagnosis of prostate cancer (PCa) have significantly increased early detection of the disease but often show unsatisfactory analytical parameters. A class of promising markers represents urinary microRNAs (miRNAs). In the last five years, there has been an extensive increase in the number of studies on this topic. Thus, this review aims to update knowledge and point out technical aspects affecting urinary miRNA analysis. The review of relevant literature was carried out by searching the PubMed database for the keywords: microRNA, miRNA, urine, urinary, prostate cancer, and diagnosis. Papers discussed in this review were retrieved using PubMed, and the search strategy was as follows: (urine OR urinary) WITH (microRNA OR miRNA) AND prostate cancer. The search was limited to the last 5 years, January 2017 to December 2021. Based on the defined search strategy, 31 original publications corresponding to the research topic were identified, read and reviewed to present the latest findings and to assess possible translation of urinary miRNAs into clinical practice. Reviews or older publications were read and cited if they valuably extended the context and contributed to a better understanding. Urinary miRNAs are potentially valuable markers for the diagnosis of prostate cancer. Despite promising results, there is still a need for independent validation of exploratory data, which follows a strict widely accepted methodology taking into account the shortcomings and factors influencing the analysis.
ER  -

JURÁČEK, Jaroslav, Marie MĄDRZYK, Michal STANÍK and Ondřej SLABÝ. Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update. \textit{CANCERS}. MDPI, 2022, vol.~14, No~13, p.~3157-3173. ISSN~2072-6694. Available from: https://dx.doi.org/10.3390/cancers14133157.

Detailed Information on Publication Record